Management of Children with Psoriasis During the COVID-19 Pandemic
The spread of new coronavirus infection (COVID-19) changes specialists' approaches to patients with chronic diseases, including those with chronic dermatoses. The high risk of COVID-19 complications in patients with psoriasis is connected to the features of disease pathogenesis (such as high ac...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
"Paediatrician" Publishers LLC
2021-11-01
|
| Series: | Вопросы современной педиатрии |
| Subjects: | |
| Online Access: | https://vsp.spr-journal.ru/jour/article/view/2750 |
| _version_ | 1826561726851579904 |
|---|---|
| author | Nikolay N. Murashkin Alexander I. Materikin Eduard T. Ambarchian Roman V. Epishev Leonid A. Opryatin Roman A. Ivanov |
| author_facet | Nikolay N. Murashkin Alexander I. Materikin Eduard T. Ambarchian Roman V. Epishev Leonid A. Opryatin Roman A. Ivanov |
| author_sort | Nikolay N. Murashkin |
| collection | DOAJ |
| description | The spread of new coronavirus infection (COVID-19) changes specialists' approaches to patients with chronic diseases, including those with chronic dermatoses. The high risk of COVID-19 complications in patients with psoriasis is connected to the features of disease pathogenesis (such as high activity of proinflammatory cytokines) and used immunosuppressive therapy. Psoriasis affects up to 1% of children in Europe, while 10-20% of them have moderate or severe form of disease. These children may require immunosuppressive treatment, including genetically engineered biological therapy. There is only limited data on adults and children with psoriasis during the COVID-19 pandemic. |
| first_indexed | 2024-03-12T03:41:28Z |
| format | Article |
| id | doaj.art-34fca9baae0a40e7996350c26424cefa |
| institution | Directory Open Access Journal |
| issn | 1682-5527 1682-5535 |
| language | English |
| last_indexed | 2025-03-14T09:36:46Z |
| publishDate | 2021-11-01 |
| publisher | "Paediatrician" Publishers LLC |
| record_format | Article |
| series | Вопросы современной педиатрии |
| spelling | doaj.art-34fca9baae0a40e7996350c26424cefa2025-03-02T11:34:24Zeng"Paediatrician" Publishers LLCВопросы современной педиатрии1682-55271682-55352021-11-0120544144510.15690/vsp.v20i5.23211980Management of Children with Psoriasis During the COVID-19 PandemicNikolay N. Murashkin0Alexander I. Materikin1Eduard T. Ambarchian2Roman V. Epishev3Leonid A. Opryatin4Roman A. Ivanov5National Medical Research Center of Children's Health; Sechenov First Moscow State Medical University (Sechenov University); Central State Medical AcademyNational Medical Research Center of Children's HealthResearch Institute of Pediatrics and Children's Health in “Central Clinical Hospital of the Russian Academy of Sciences”National Medical Research Center of Children's HealthNational Medical Research Center of Children's HealthNational Medical Research Center of Children's HealthThe spread of new coronavirus infection (COVID-19) changes specialists' approaches to patients with chronic diseases, including those with chronic dermatoses. The high risk of COVID-19 complications in patients with psoriasis is connected to the features of disease pathogenesis (such as high activity of proinflammatory cytokines) and used immunosuppressive therapy. Psoriasis affects up to 1% of children in Europe, while 10-20% of them have moderate or severe form of disease. These children may require immunosuppressive treatment, including genetically engineered biological therapy. There is only limited data on adults and children with psoriasis during the COVID-19 pandemic.https://vsp.spr-journal.ru/jour/article/view/2750childrenpsoriasiscovid-19etanercept |
| spellingShingle | Nikolay N. Murashkin Alexander I. Materikin Eduard T. Ambarchian Roman V. Epishev Leonid A. Opryatin Roman A. Ivanov Management of Children with Psoriasis During the COVID-19 Pandemic Вопросы современной педиатрии children psoriasis covid-19 etanercept |
| title | Management of Children with Psoriasis During the COVID-19 Pandemic |
| title_full | Management of Children with Psoriasis During the COVID-19 Pandemic |
| title_fullStr | Management of Children with Psoriasis During the COVID-19 Pandemic |
| title_full_unstemmed | Management of Children with Psoriasis During the COVID-19 Pandemic |
| title_short | Management of Children with Psoriasis During the COVID-19 Pandemic |
| title_sort | management of children with psoriasis during the covid 19 pandemic |
| topic | children psoriasis covid-19 etanercept |
| url | https://vsp.spr-journal.ru/jour/article/view/2750 |
| work_keys_str_mv | AT nikolaynmurashkin managementofchildrenwithpsoriasisduringthecovid19pandemic AT alexanderimaterikin managementofchildrenwithpsoriasisduringthecovid19pandemic AT eduardtambarchian managementofchildrenwithpsoriasisduringthecovid19pandemic AT romanvepishev managementofchildrenwithpsoriasisduringthecovid19pandemic AT leonidaopryatin managementofchildrenwithpsoriasisduringthecovid19pandemic AT romanaivanov managementofchildrenwithpsoriasisduringthecovid19pandemic |